VILDAGLIPTIN 50MG*
ANTIDIABETIC
Management Of Type 2 Diabetes Mellitus
50mg Once Daily
Vildagliptin Is A Dpp-4 Inhibitor Used For The Management Of Type 2 Diabetes Mellitus. It Potentiates Incretin Effects, Thereby Enhancing Insulin Secretion And Inhibiting Glucagon Release. This Therapy Can Be Used As A Monotherapy Or In Combination With Other Oral Antidiabetics To Improve Glycemic Control. Commonly Monitored For Adverse Effects Such As Pancreatitis.
Hypersensitivity
Risk Of Pancreatitis Use With Caution In Patients With Renal Impairment